Evaluation of the safety of a new inactivated vaccine against porcine parvovirus and Erysipelothrix rhusiopathiae under field conditions

Home Knowledge Evaluation of the safety of a new inactivated vaccine against porcine parvovirus and Erysipelothrix rhusiopathiae under field conditions

Evaluation of the safety of a new inactivated vaccine against porcine parvovirus and Erysipelothrix rhusiopathiae under field conditions

The aim of this study was to evaluate the safety of a new inactivated vaccine against Porcine Parvovirus (PPV) and Erysipelothrix rhusiopathiae under field conditions.

About this article

Appeared in

ESPHM Congress, 2014

Authors

Noguera, M.; Puig, A.; Simon, M.; Peroxo, E.; Fontseca, M.; Camprodon, A.; March, R.

Summary

No severe or unexpected adverse events attributable to the vaccination with the new vaccine were observed, independently of the target category: nulliparous or multiparous. None of the sows vaccinated with the new vaccine showed abnormal general or local clinical signs from causes attributable to the vaccination. The average rectal temperature increase for all evaluated sows vaccinated did not exceed 1.5ºC. No sow vaccinated with the new vaccine showed abnormal reproductive performance from causes attributable to the vaccination. No differences regarding the safety parameters between both vaccines were observed.

Related services

Related products

Share this on